Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target.
about
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsPlatelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk predictionImpact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target.Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.Darapladib.Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection.Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis.Lipoprotein-associated phospholipase A2: a new marker to determine cardiovascular risk in hypercholesterolemic dyslipidaemic children.Prognostic value of serum LP-PLA2 and hs-CRP in unstable atherosclerotic plaques.Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages.Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus.Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle-brachial index.Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases.Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes.Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.
P2860
Q26777871-A2B19100-2466-4CC3-8601-191625C0FE25Q35621992-924001E8-EDD0-40DA-8BCB-2C4C90245418Q36013005-F87CA01B-6B1A-47B4-80F4-E3D9CEF29DF5Q36024430-0C1F7BAD-3BB0-4A16-8B1A-E4A058A1CC3DQ36187055-300E63DA-D938-4380-8594-67DC9CA23246Q36269180-5333BF18-201F-4122-B323-70791E803107Q37445865-9A2F31DC-F678-4314-9A2B-8EC34AAFC7D9Q37650398-333AD57F-E028-4D2B-8EA9-3A67A7AF91C5Q39404652-8A684EAA-68B7-41B2-9C4A-7BE33C3AFA02Q40275828-FA2FC628-B4E1-421B-9180-239CA19F5BE3Q40587146-B4052F4A-2192-4051-A461-7F01EE4AB320Q41430429-48A5EF6B-92B7-40E0-BCB2-96EEB4AC35ACQ43750480-750A708A-963A-4CC9-BEF1-8A54C1C902D7Q44336199-2A3EAECF-D4E5-4812-A373-EA7F29F11E16Q44882278-94BC06E2-8F6E-4143-ABFA-C1E7555878E4Q45200533-2979F132-7EC7-44B0-8674-3D289AAB9940Q46863353-A6E6FA20-EBA8-4898-8EF3-93F1C989A259Q47611058-5F63BCB4-90C5-4618-9690-FBEF2A70C67DQ50102181-7AE730F1-C88F-4097-BDBB-EE91D9AE2711
P2860
Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@ast
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@en
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@nl
type
label
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@ast
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@en
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@nl
prefLabel
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@ast
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@en
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@nl
P1476
Lipoprotein-associated phospho ...... ease and a therapeutic target.
@en
P2093
C H Macphee
P304
P356
10.1016/S1471-4892(01)00024-8
P577
2001-04-01T00:00:00Z